MRE11 and esophageal squamous cell carcinoma: Moreover, UBQLN4 binds to MRE11 and promotes MRE11 degradation, leading to cisplatin-resistance in cancer cells, i.e., esophageal squamous cell carcinoma (ESCC) [93].